FDA approves ablation catheters
Links shared publicly online about this topic.
- 2,276total visits
FDA approves ablation catheters
View full resource at theheart.org
Tags: Heart Disease, Arrhythmia, Atrial Fibrillation, Drug, FDA
Most Recently Shared on February 6, 2009 at 11:35 pm By:
FDA approves AF ablation catheters http://tinyurl.com/c65a4f
Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter
news-medical.net — “Boston Scientific Corporation today announced Health Canada approval of the Blazer Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.” View full resource at news-medical.net
Most Recently Shared on March 15, 2012 at 2:05 pm By:
Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter: Boston Scientific Corporation tod... http://t.co/ZtVd5Sce
Difficult IV Access? EZ Vein to the Rescue!
medgadget.com — “According to The Oklahoman, the FDA approved the EZ Vein, a new device developed by an Oklahoma doctor for easing the placement of intravenous catheters in” View full resource at medgadget.com
Most Recently Shared on December 14, 2011 at 8:42 pm By:
[News] Difficult IV Access? EZ Vein to the Rescue! http://t.co/yx0GIn22 #medicaldevice
FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy - MarketWatch
marketwatch.com — “FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on September 20, 2011 at 1:05 am By:
JanCerny, MD, PhD Internist, Oncologist, Hematologist, Physician, Doctor, and PhD
FDA Approves New Indications for Denosumab to Treat Bone Loss in Pts With Prostate or Breast CA on Hormonal Therapy http://ow.ly/6yY3i
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
drugs.com — “Prolia (denosumab) is used in the treatment of bone loss in patients with prostate or breast cancer undergoing hormone ablation therapy. Includes Prolia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 20, 2011 at 1:04 am By:
Drugs and Devices OW OW Health
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prosta... http://t.co/vescEIgy #drug
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
drugs.com — “Prolia (denosumab) is used in the treatment of bone loss in patients with prostate or breast cancer undergoing hormone ablation therapy. Includes Prolia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 20, 2011 at 12:39 am By:
FDA Approves New Indications for Prolia (denosumab) for Cancer Treatment-Induced Bone Loss - http://t.co/f77E3osL
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated In Clinical Trials Using The ExAblate(R) Non-Invasive Prostate System
medicalnewstoday.com — “InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate® system for treating uterine fibroids, announced toda” View full resource at medicalnewstoday.com
Most Recently Shared on July 14, 2011 at 9:38 am By:
Drugs and Devices OW OW Health
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated In Clinical Trials Using T... http://bit.ly/oxnrif #MedDevice
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated In Clinical Trials Using The ExAblate(R) Non-Invasive Prostate System
medicalnewstoday.com — “InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate® system for treating uterine fibroids, announced toda” View full resource at medicalnewstoday.com
Most Recently Shared on July 14, 2011 at 8:05 am By:
MNT Drug Approvals Health News
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated In Clinical Trials Using The ExAblate(R) No... http://mnt.to/3Yfq
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials Using the ExAblate(R) Non-Invasive Prostate Cancer System - Health News - redOrbit
redorbit.com — “TIRAT CARMEL, Israel, July 13, 2011 /PRNewswire/ -- Initial Results are Encouraging, Spurring Hope for a Treatment Option With a Lower Rate of Complications InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that 23 patients with organ confined low risk prostate cancer have already been treated with its ExAblate(R) system in clinical trials, showing pro” View full resource at redorbit.com
Most Recently Shared on July 13, 2011 at 5:48 pm By:
Urology & Nephrology OW Health
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials Using the ExAblate... http://bit.ly/qwJIsc
FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension
news-medical.net — “Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.” View full resource at news-medical.net
Most Recently Shared on July 12, 2011 at 6:46 am By:
Stroke News: FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension: Medtronic, ... http://twurl.nl/wwvm6n
FDA approves Achieve Mapping Catheter for use in first patient procedure
news-medical.net — “Medtronic, Inc. today announced the U.S. Food and Drug Administration approval for use, and the first patient procedure using the Achieve™ Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.” View full resource at news-medical.net
Most Recently Shared on May 3, 2011 at 5:17 am By:
FDA approves Achieve Mapping Catheter for use in first patient procedure: Medtronic, Inc. today announced the U.... http://bit.ly/lAhEVP
Medtronic Announces FDA Clearance And First Patient Procedure With The Achieve™ Mapping Catheter
medicalnewstoday.com — “Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval for use, and the first patient procedure using the Achieve™ Mapping Catheter, an intra-cardiac” View full resource at medicalnewstoday.com
Most Recently Shared on May 2, 2011 at 3:22 pm By:
Medtronic Announces FDA Clearance And First Patient Procedure With The Achieve™ Mapping Catheter: Medtronic, Inc. (NYSE.. http://dld.bz/Y5wB
GAO renews critique of FDA medical device system | The Associated Press | Congress | San Francisco Examiner
sfexaminer.com — “Government investigators say the Food and Drug Administration is putting patients at risk by approving sensitive medical devices such as hip joints and heart defibrillators under the same streamlined system intended for power wheelchairs, stitches and catheters.” View full resource at sfexaminer.com
Most Recently Shared on April 14, 2011 at 11:04 am By:
Drugs and Devices OW OW Health
GAO renews critique of FDA medical device system: MATTHEW PERRONE AP Health Writer WASHINGTON Government investi... http://bit.ly/g8GUwx
GAO renews critique of FDA medical device system - seattlepi.com
seattlepi.com — “WASHINGTON (AP) â--" Government investigators say the Food and Drug Administration is putting patients at risk by approving sensitive medical devices such as hip joints and heart defibrillators under the same streamlined system intended for power wheelchairs, stitches and catheters. The GAO previously faulted the FDA in a 2009 for not reclassifying more than 26 types of devices so they receive more stringent reviews. [...] the agency has cleared 67 individual, high-risk devices through the” View full resource at seattlepi.com
Most Recently Shared on April 13, 2011 at 11:02 pm By:
Drugs and Devices OW OW Health
GAO renews critique of FDA medical device system: share: digg facebook twitter WASHINGTON (AP) — Government inve... http://bit.ly/hykzyH
St. Jude Medical Receives FDA Approval For New Bi-Directional Ablation Catheters
medicalnewstoday.com — “St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) approval of two new irrigated ablation catheters -” View full resource at medicalnewstoday.com
Most Recently Shared on April 5, 2011 at 9:05 am By:
MNT Drug Approvals Health News
St. Jude Medical Receives FDA Approval For New Bi-Directional Ablation Catheters http://mnt.to/3T9M #regulatory
Crospon Receives FDA Approval For Latest EndoFLIP Product
medicalnewstoday.com — “Crospon, an Irish medical device developer based in Galway, has announced that the Company has received clearance from the US Food and Drugs Administration (FDA) to market a new imaging catheter” View full resource at medicalnewstoday.com
Most Recently Shared on January 9, 2011 at 11:10 am By:
Drugs and Devices OW OW Health
Crospon Receives FDA Approval For Latest EndoFLIP Product: Crospon, an Irish medical device developer... http://mnt.to/f/3PMd #MedDevice
Advertisement
